Central Anticholinergic Syndrome with the Antimalarial Drug Mefloquine

  • Speich R
  • Haller A
35Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

To the Editor: The neuropsychiatric side effects of the antimalarial drug mefloquine are well documented 1 , 2 . They include anxiety, depression, hallucinations, acute psychosis, and seizures. The incidence of these side effects is 1 in 13,000 with prophylactic use and 1 in 250 with therapeutic use 2 . The mechanism of action is unknown 1 . A 47-year-old, previously healthy Japanese tourist was admitted to our hospital because of severe falciparum malaria with parasitemia of 24 percent after a trip to Zaire without any antimalarial chemoprophylaxis. Treatment consisted of 750 mg of quinine per day and 450 mg of clindamycin three times. © 1994, Massachusetts Medical Society. All rights reserved.

Cite

CITATION STYLE

APA

Speich, R., & Haller, A. (1994). Central Anticholinergic Syndrome with the Antimalarial Drug Mefloquine. New England Journal of Medicine, 331(1), 57–58. https://doi.org/10.1056/nejm199407073310120

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free